We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.04B
AUM Growth
+$45.1M
Cap. Flow
-$10.2M
Cap. Flow %
-0.98%
Top 10 Hldgs %
71.58%
Holding
66
New
–
Increased
3
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$96.4K
2
WAT icon
Waters Corp
WAT
+$77.9K
3
JKHY icon
Jack Henry & Associates
JKHY
+$77.8K

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$3.59M
2
BNY
Bank of New York Mellon
BNY
+$2.39M
3
MMM icon
3M
MMM
+$2.09M
4
WFC icon
Wells Fargo
WFC
+$729K
5
USB icon
US Bancorp
USB
+$688K

Sector Composition

Rank Sector Weight
1 Financials 49.03%
2 Healthcare 18.14%
3 Materials 7.91%
4 Energy 6.82%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
51
MetLife
MET
$61.5B
$598K 0.06%
10,580
– –
IEX icon
52
IDEX
IEX
$17.5B
$583K 0.06%
2,710
– –
PRU icon
53
Prudential Financial
PRU
$42.2B
$560K 0.05%
6,350
– –
BTI icon
54
British American Tobacco
BTI
$122B
$559K 0.05%
16,850
– –
BN icon
55
Brookfield
BN
$110B
$437K 0.04%
19,500
– –
VEEV icon
56
Veeva Systems
VEEV
$38.4B
$395K 0.04%
2,000
– –
VYM icon
57
Vanguard High Dividend Yield ETF
VYM
$83.8B
$258K 0.02%
2,430
– –
ALDX icon
58
Aldeyra Therapeutics
ALDX
$91.1M
$168K 0.02%
20,020
– –
ALPN
59
DELISTED
Alpine Immune Sciences Inc
ALPN
$128K 0.01%
12,445
– –
CRVS icon
60
Corvus Pharmaceuticals
CRVS
$1.24B
$114K 0.01%
49,959
– –
OCUL icon
61
Ocular Therapeutix
OCUL
$2.14B
$88K 0.01%
17,000
– –
AKTX
62
Akari Therapeutics
AKTX
$13.5M
$22K ﹤0.01%
164
– –
ASHR icon
63
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
– –
-11,700
Closed -$345K
VZ icon
64
Verizon
VZ
$196B
– –
-7,800
Closed -$303K
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q2 2023 Portfolio in Review

As of Q2 2023, Hikari Power held 66 positions worth $1.04B, up 4.5% from $995M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3%. Hikari Power opened no new positions and exited 2, leaving the 66-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power added most to Cigna in Q2 2023, an estimated $96.4K increase.
  • Hikari Power's biggest Q2 2023 reduction was Novo Nordisk, cutting an estimated $3.59M.
  • Hikari Power fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2023, selling an estimated $345K.
  • Hikari Power's ten largest holdings make up 72% of its $1.04B portfolio in Q2 2023.
  • Hikari Power opened 0 new positions and closed 2 in Q2 2023.
  • Hikari Power's portfolio value rose 4.5% quarter-over-quarter to $1.04B.

Based on Hikari Power's 13F filing for Q2 2023, filed 26 Jul 2023.